PRTCPureTech Health Plc
Slide 1 of 3
Company Overview
Name
PureTech Health Plc
52W High
$24.99
52W Low
$13.30
Market Cap
$502.6M
Dividend Yield
0%
Price/earnings
0.21
P/E
0.21
Tags
Dividends
No dividend
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 2 of 3
Income Statement
Total Revenue
$47.6M
Operating Revenue
$46.7M
Total Gross Profit
$154.7M
Total Operating Income
$175.7M
Net Income
$326.2M
EV to EBITDA
-$51.93
EV to Revenue
$271.84
Price to Book value
Price to Earnings
$0.00
Additional Data
Other Revenue
$1M
Selling, General & Admin Expense
$71.5M
Research & Development Expense
$69.5M
Other Operating Expenses / (Income)
$-161.9M
Impairment Charge
N/A
Total Operating Expenses
$21M
Slide 3 of 3
Earnings History
Estimated EPS
Reported EPS
N/A Slide 1 of 5
Company Overview
Name
PureTech Health Plc
52W High
$24.99
52W Low
$13.30
Market Cap
$502.6M
Dividend Yield
0%
Price/earnings
0.21
P/E
0.21
Tags
Dividends
No dividend
Slide 2 of 5
Sentiment
Score
Mixed
50
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 3 of 5
Income Statement
Total Revenue
$47.6M
Operating Revenue
$46.7M
Total Gross Profit
$154.7M
Total Operating Income
$175.7M
Net Income
$326.2M
EV to EBITDA
-$51.93
EV to Revenue
$271.84
Price to Book value
Price to Earnings
$0.00
Slide 4 of 5
Additional Data
Other Revenue
$1M
Selling, General & Admin Expense
$71.5M
Research & Development Expense
$69.5M
Other Operating Expenses / (Income)
$-161.9M
Impairment Charge
N/A
Total Operating Expenses
$21M
Slide 5 of 5
Earnings History
Estimated EPS
Reported EPS
N/AUpcoming Earnings
We were not able to find an announced earnings date for this symbol yet. Check back again later
Company Info
CEO
Daphne Zohar
Location
Massachusetts, USA
Exchange
Nasdaq
Website
https://puretechhealth.com
Summary
PureTech Health plc discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases.
Company Info
CEO
Daphne Zohar
Location
Massachusetts, USA
Exchange
Nasdaq
Website
https://puretechhealth.com
Summary
PureTech Health plc discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases.
